This brand name is authorized in Austria, Croatia, Cyprus, Ecuador, Finland, Hong Kong SAR China, Poland, Singapore.
The drug NEUROBION contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
8K0I04919X - THIAMINE MONONITRATE
|
|
Thiamine pyrophosphate (TPP), the coenzymatic form of thiamine, is involved in two main types of metabolic reactions: decarboxylation of α-ketoacids (e.g. pyruvate, α-ketoglutarate and branched-chain keto acids) and transketolation (e.g. among hexose and pentose phosphates). Therefore, the principal physiological role of thiamine is as a coenzyme in carbohydrate metabolism, where TPP is required for several stages in the breakdown of glucose to provide energy. |
|
2
|
UNII
68Y4CF58BV - PYRIDOXINE HYDROCHLORIDE
|
|
Pyridoxine hydrochloride is Vitamin B6. It is converted to pyridoxal phosphate which is the co-enzyme for a variety of metabolic transformations. It is essential for human nutrition. |
|
3
|
UNII
P6YC3EG204 - CYANOCOBALAMIN
|
|
Hydroxocobalamin is used in the treatment and prevention of Vitamin B12 deficiency. For adults, the daily requirement of Vitamin B12 is probably about 1 to 2 micrograms and this amount is present in most normal diets. However, Vitamin B12 only occurs in animal products, not in vegetables, and therefore strict vegetarian or vegan diets that exclude dairy products may provide an inadequate amount, although a deficiency may not be apparent for many years. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| NEUROBION Solution for injection | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| NEUROBION Coated tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A11DB | Vitamin B1 in combination with vitamin B6 and/or vitamin B12 | A Alimentary tract and metabolism → A11 Vitamins → A11D Vitamin B1, plain and in combination with vitamin B6 and B12 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 2321-MEN-0818, 4277-MEE-0618, 7615-MEE-1122, H5850713 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 572305, 572313 |
| HK | Department of Health Drug Office | 04100, 04104 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-554925238 |
| PL | Rejestru Produktów Leczniczych | 100414661 |
| SG | Health Sciences Authority | 06258P, 06262P, 15098P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.